Insight

Aug 31, 2024, 17:06

Amir Safavi: How to improve the safety of SABR for ultra central thoracic tumors?

Amir Safavi, Radiation Oncology Fellow at Memorial Sloan Kettering Cancer Centre ,shared a post on X:

“Risk mitigation strategies for ultracentral lung tumors in IJROBP – The Red Journal:

Moderate plan dmax (eg 110-120%).
Limit OAR hotspots (esp Esophagus).
Avoid overly generous PTV.
Nodes treated cooler (eg 35/5) Accurate target and OAR contouring (use contrast).“Beyond the HILUS Trial: How Can We Improve the Safety of SABR for Ultracentral Thoracic Tumors?Authors: Amir H. Safavi, David A. Palma and Meredith E. Giuliani

Source: Amir Safavi/X

Amir Safavi cancer David A. Palma IJROBP - The Red Journal LCSM Memorial Sloan Kettering Cancer Centre Meredith E. Giuliani OncoDaily Oncology SABR SBRT ultracentral lung

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Dana Dornsife: After 19 Years, Lazarex Cancer Foundation Is Shuttering Because of Lack of Funding